Intranasal drug administration for procedural sedation in children admitted to pediatric Emergency Room.
C. Fantacci, G. C. Fabrizio, +2 authors A. Chiaretti
Published 2018
Medicine
European review for medical and pharmacological sciences
www.europeanreview.org/wp/wp-content/...ation-in-children.pdf
Pharmacokinetics and pharmacodynamics of intranasal remimazolam—a randomized controlled clinical trial
Marija Pesic, F. Schippers, Rob Saunders, L. Webster, Martin Donsbach, T. Stoehr
Medicine
European journal of clinical pharmacology
4 September 2020
www.semanticscholar.org/author/Rob-Saunders/1925006360
Purpose Remimazolam is a novel and ultra-short-acting sedative currently developed for intravenous use in procedural sedation, general anesthesia, and ICU sedation. However, intravenous… Expand